Recent articles, videos and podcasts

Belluscura navigates trade tariff headwinds, revises FY25 outlook

2 hours ago

Belluscura has withdrawn its FY25 guidance in response to US-China tariff tensions but remains well-positioned to navigate the challenges with strong leadership and ample capital.

Exchange with John Rosier

1 day ago

In this investing masterclass, John Rosier - ex fund manager, professional investor & author of John's Investment Chronicle - takes me through his view of the markets and latest thoughts on 18 companies

Verici Dx sees 68% Q1 growth in Tutivia test orders, Medicare coverage decision imminent

1 day ago

Verici Dx reported a 68% increase in Tutivia test orders in Q1 2025, with growth expected to continue pending an upcoming decision on Medicare coverage.

US tariff crisis: short-term weakness, but a potential bounce ahead

1 day ago

As US tariffs create short-term market volatility, investors may see a bounce in the coming months as distressed selling eases and strategic trade deals unfold.

Directors back Argentex after strong FY24 results, CEO Ormonde invests £150k amid growth plans

4 days ago

Five directors, including CEO Jim Ormonde, have made substantial investments in Argentex following the group's positive FY24 results, as it prepares to launch new services aimed at expanding its forex and treasury solutions.

Small-cap Investing with Paul Hill and Paul Scott

5 days ago

In this week’s smallcap investing show, UK analyst & stock markets commentator Paul Scott & I discussed our latest thoughts 18 ideas.

US markets sink as tariff shock hits growth and inflation outlook

5 days ago

US stocks plunge following Trump’s tariff announcement, as investors brace for potential economic fallout on American GDP, inflation, and corporate earnings.

Watchlist